Ann Dermatol.  2014 Aug;26(4):522-523. 10.5021/ad.2014.26.4.522.

Decreased Serum Level of Interferon-gamma in Patients with Pityriasis Rosea

• Zeng M
• Zhao SX
• Liu LH
• Zuo XB
• Zheng XD
• Li T
• Zhang M
• Wang PG
• Yang S

• KMID: 2265599
• DOI: http://doi.org/10.5021/ad.2014.26.4.522

Abstract

No abstract available.

MeSH Terms

Humans
Interferon-gamma*
Pityriasis Rosea*
Interferon-gamma

Figure

• 

  Fig. 1 Serum levels of interferon-γ(IFN-γ) in patients with pityriasis rosea (PR) and in healthy controls. Statistical significance: p<0.05 vs. control.

Reference

1. Rebora A, Drago F, Broccolo F. Pityriasis rosea and herpesviruses: facts and controversies. Clin Dermatol. 2010; 28:497–501.

2. Neoh CY, Tan AW, Mohamed K, Sun YJ, Tan SH. Characterization of the inflammatory cell infiltrate in herald patches and fully developed eruptions of pityriasis rosea. Clin Exp Dermatol. 2010; 35:300–304.

3. Rajpara SN, Ormerod AD, Gallaway L. Adalimumab-induced pityriasis rosea. J Eur Acad Dermatol Venereol. 2007; 21:1294–1296.

4. Nastke MD, Becerra A, Yin L, Dominguez-Amorocho O, Gibson L, Stern LJ, et al. Human CD4+ T cell response to human herpesvirus 6. J Virol. 2012; 86:4776–4792.

5. Gangemi S, Minciullo PL, Guarneri F, Cristani M, Arcoraci T, Spatari G, et al. Increased serum levels of interleukin-22 in patients affected by pityriasis rosea. J Eur Acad Dermatol Venereol. 2009; 23:858–859.

6. Gangemi S, Cannavò SP, Guarneri F, Merendino RA, Sturniolo GC, Minciullo PL, et al. The CX3C-chemokine fractalkine (CX3CL1) is detectable in serum of patients affected by active pityriasis rosea. J Eur Acad Dermatol Venereol. 2006; 20:1366–1367.

7. Qiu Y, Huang Y, Chen J, Qiao D, Zeng G, Cai J. Depletion of IL-22 during culture enhanced antigen-driven IFN-γ production by CD4(+)T cells from patients with active TB. Immunol Lett. 2013; 150:48–53.